Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 5, 2013, Pages 627-633

  St Jules, David E ^a   Watters, Corilee A ^a   Brunt, Elizabeth M ^b   Wilkens, Lynne R ^a   Novotny, Rachel ^a   Belt, Patricia ^c   Lavine, Joel E ^d,m   Abrams, Stephanie H ^e   Himes, Ryan ^e   Krisnamurthy, Rajesh ^e   Maldonado, Leanel ^e   Morris, Beverly ^e   Bernstein, Kimberlee ^f   Cecil, Kim ^f   DeVore, Stephanie ^f   Kohli, Rohit ^f   Lake, Kathleen ^f   Podberesky, Daniel ^f   Slaughter, Crystal ^f   Xanthakos, Stavra ^f   Behr, Gerald ^d   Mencin, Ali ^d   Ovchinsky, Nadia ^d   Reynoso, Elena ^d   Alazraki, Adina ^g   Cleeton, Rebecca ^g   Karpen, Saul ^g   Raviele, Nicholas ^g   Vos, Miriam ^g   Byam, Elizabeth ^h   Cummings, Oscar W ^h   Fleming, Cynthia ^h   Klipsch, Ann ^h   Molleston, Jean P ^h   Sandrasegaran, Kumar ^h   Subbarao, Girish ^h   Pfeifer, Kimberly ⁱ   Scheimann, Ann ⁱ   Torbenson, Michael ⁱ   Clark, Jeanne M ^c   Corless, Erin ^c   Donithan, Michele ^c   Isaacson, Milana ^c   May, Kevin P ^c   Miriel, Laura ^c   Sternberg, Alice ^c   Tonascia, James ^c   Ünalp Arida, Aynur ^c   Van Natta, Mark ^c   Vaughn, Ivana ^c   Wilson, Laura ^c   Yates, Katherine ^c   Arnon, Ronen ^j   Boyd, Mariel ^j   Amsden, Katie ^k   Fishbein, Mark H ^k   Kirwan, Elizabeth ^k   Mohammad, Saeed ^k   Quinn, Ann ^k   Rigsby, Cynthia ^k   Whitington, Peter F ^k   Barlow, Sarah ^l   Derdoy, Jose ^l   Jain, Ajay ^l   King, Debra ^l   Osmack, Pat ^l   Siegner, Joan ^l   Stewart, Susan ^l   Romo, Dana ^l   Arroyo, Sandra ^m   Behling, Cynthia ^m   Collins, Jennifer ^m   Durelle, Janis ^m   Middleton, Michael ^m   Newton, Kimberly ^m   Paiz, Melissa ^m   Schwimmer, Jeffrey B ^m   Sirlin, Claude ^m   Ugalde Nicalo, Patricia ^m   Aouizerat, Bradley ⁿ   Ferrell, Linda D ⁿ   Fleck, Shannon ⁿ   Gill, Ryan ⁿ   Langlois, Camille ⁿ   Perito, Emily Rothbaum ⁿ   Rosenthal, Philip ⁿ   Tsai, Patrika ⁿ   Cooper, Kara ^o   Horslen, Simon ^o   Hsu, Evelyn ^o   Murray, Karen ^o   Otto, Randolph ^o   Rich, Deana ^o   Yeh, Matthew ^o   Young, Melissa ^o   Fowler, Kathryn ^b   more..

^a UNIVERSITY OF HAWAII   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g EMORY UNIVERSITY   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j Mount Sinai Kravis Children's Hospital   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l SAINT LOUIS UNIVERSITY   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

more..

Author keywords

3; adolescents; fatty acid; fish; nonalcoholic fatty liver disease

Indexed keywords

OMEGA 3 FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIETARY INTAKE; FEMALE; FISH; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; CHILD; CHILD BEHAVIOR; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CROSS-SECTIONAL STUDIES; DIET; DISEASE SUSCEPTIBILITY; FATTY ACIDS, OMEGA-3; FATTY LIVER; FEMALE; FISHES; HEALTH PROMOTION; HUMANS; LIVER; MALE; NUTRITION POLICY; PATIENT COMPLIANCE; SEAFOOD; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84888128557     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182a1df77     Document Type: Article

References (35)

1. Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-Alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009;48:1-26
2. Carter-Kent C, Yerian LM, Brunt EM, et al. Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study. Hepatology 2009;50:1113-20
3. Kohli R, Boyd T, Lake K, et al. Rapid progression of NASH in childhood. JPGN 2009;50:453-6
4. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009;106:15430-5
5. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-Alcoholic fatty liver disease in children: A followup study for up to 20 years. Gut 2009;58:1538-44
6. Shapiro H, Tehilla M, Attal-Singer J, et al. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 2011;30:6-19
7. Masterton GS, Plevris JN, Hayes PC. Review article: Omega-3 fatty acids-A promising novel therapy for non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2010;31:679-92
8. Araya J, Rodrigo R, Pettinelli P, et al. Decreased liver fatty acid v-6 and v-5 desaturase activity in obese patients. Obesity 2010;18:1460-3
9. Araya J, Rodrigo R, Videla LA, et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-Alcoholic fatty liver disease. Clin Sci (Lond) 2004; 106:635-43
10. Parker HM, Johnson NA, Burdon CA, et al. Omega-3 supplementation and non-Alcoholic fatty liver disease: A systematic review and metaanalysis. J Hepatol 2012;56:944-51
11. Nobili V, Bedogni G, Alisi A, et al. Docosahexaenoic acid supplementation decreases liver fat content in children with non-Alcoholic fatty liver disease: Double-blind randomized controlled clinical trial. Arch Dis Child 2011;96:350-3
12. Mager DR, Patterson C, So S, et al. Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr 2010;64:628-35
13. Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial. JAMA 2011;305:1659-68
14. Patton H, Lavine JE, Van Natta ML, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis (NASH). Gastroenterology 2008;135:1961-71
15. Lavine JE, Schwimmer JB, Molleston JP, et al. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials 2010;31:62-70
16. NutritionQuest, Assessment and Analysis Services. Assessment tools and analysis services. http://nutritionquest.com/assessment. Published 2009. Accessed January 19, 2012
17. Vos MB, Colvin R, Belt P, et al. Correlation of vitamin E, uric acid, and diet composition with histological features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012;54:90-6
18. Ervin RB, Wright JD, Wang C, et al. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Adv Data 2004; 348:1-6
19. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-79
20. Blasbalg TL, Hibbeln JR, Ramsden CE, et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 2011;93:950-62
21. Kleiner DE, Brunt EM, Natta MV, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21
22. Centers for Disease Control and Prevention. Percentile data files with LMS values. http://www.cdc.gov/growthcharts/percentile-data-files. htm. Published August 4, 2009. Accessed August 25, 2012
23. Deleted in proof
24. Koletzko B, Uauy R, Palou A, et al. Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children-A workshop report. Br J Nutr 2010;103:923-8
25. Kris-Etherton PM, Grieger JA, Etherton TD. Dietary reference intakes for DHA and EPA. Prostaglandins Leukot Essent Fatty Acids 2009; 81:99-104
26. Tooze JA, Midthune D, Dodd KW, et al. A new method for estimating the usual intake of episodically-consumed foods with application to the distribution. J Am Diet Assoc 2006;106:1575-87
27. Quiros-Tejeira RE, Rivera CA, Ziba TT, et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI -95th percentile. JPGN 2007;44:228-36
28. Harel Z, Riggs S, Vaz R, et al. Omega-3 polyunsaturated fatty acids in adolescents: Knowledge and consumption. J Adolesc Health 2001;28: 10-5
29. Brunt EM, Kleiner DE,Wilson LA, et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): Clinicopathologic correlations from the Nonalcoholic Steatohepatitis Clinical Research Network. Hepatology 2009;49:809-20
30. Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012;32:3-13
31. Gonzalez-Periz A, Horrillo R, Ferre N, et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by v-3 fatty acids: A role for resolvins and protectins. FASEB J 2009;23:1946-57
32. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-98
33. Santoro N, Savoye M, Kim G, et al. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS ONE 2012;7:e37827
34. Watters CA, Edmonds CM, Rosner LS, et al. A cost analysis of EPA and DHA in fish, supplements and foods. J Nutr Food Sci 2012;2:159
35. Lemke SL, Vicini JL, Su H, et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: Randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 2010;92:766-75 Diseases Diseases Diseases Diseases Diseases Diseases Diseases Diseases Diseases